Position in NBIX
as of Mar 31, 2026
· filed May 29, 2026
Position Value
$8,569,687
-$38,383,134 QoQ
Shares Held
65,050
-80.4% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
0.17%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in NBIX Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026PERCEPTIVE ADVISORS LLC holds $200,430,720 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #3 (4.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMLX |
Amylyx Pharmaceuticals, Inc.
|
8,284,882 | $115,159,859 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
7,434,033 | $70,771,994 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
This page
|
65,050 | $8,569,687 | |
| 4 | EOLS |
Evolus, Inc.
|
1,286,862 | $5,289,002 | |
| 5 | CPIX |
Cumberland Pharmaceuticals Inc
|
196,978 | $640,178 |
All Filings in NBIX
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $8,569,687 | 65,050 | Shares | Sole | 2026-05-29 | |
| 2025-12-31 | $46,952,821 | 331,050 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $63,178,019 | 450,050 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $32,057,234 | 255,050 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $11,065,530 | 100,050 | Shares | Sole | 2025-08-06 | |
| 2024-12-31 | $13,656,825 | 100,050 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $24,452,910 | 212,228 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $89,472,972 | 649,909 | Shares | Sole | 2024-08-16 | |
| 2024-03-31 | $110,944,089 | 804,409 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $35,679,817 | 270,794 | Shares | Sole | 2024-02-26 | |
| 2023-09-30 | $17,914,725 | 159,242 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $9,434,715 | 100,050 | Shares | Sole | 2023-08-24 | |
| 2023-03-31 | $10,127,061 | 100,050 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $11,949,972 | 100,050 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $10,626,310 | 100,050 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $38,786,122 | 397,888 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $37,091,156 | 395,639 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $41,137,706 | 483,007 | Shares | Sole | 2022-05-04 | |
| 2021-09-30 | $46,325,201 | 483,007 | Shares | Sole | 2021-12-03 | |
| 2021-06-30 | $79,007,490 | 811,832 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $91,593,162 | 941,832 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $182,039,757 | 1,899,215 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $148,924,434 | 1,548,715 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $261,252,020 | 2,141,410 | Shares | Sole | 2020-08-17 | |
| 2020-03-31 | $265,125,412 | 3,063,263 | Shares | Sole | 2020-05-18 | |
| No filing history on record for this holder in this stock. | ||||||